Skip to main content
Premium Trial:

Request an Annual Quote

John Maraganore, Alan Spoon, John Green, Tom DiLenge

Premium

Archemix, a developer of aptamer-based therapeutics, said this week that John Maraganore has been appointed to its board of directors.

Maraganore is currently president and CEO of Alnylam Pharmaceuticals.


LRN, a provider of corporate ethics, compliance, and governance solutions, said this week that it has appointed Alan Spoon to its board.

Spoon is managing general partner for Polaris Venture Partners, an institutional investor in Alnylam Pharmaceuticals.


ComScore Networks, a provider of Internet user information, recently appointed John Green as its CFO.

Green previously served as CFO and US Services Business leader for Invitrogen subsidiary BioReliance.


Tom DiLenge was recently named vice-president and general counsel of the Biotechnology Industry Organization.

DiLenge joined BIO in November 2005 as deputy general counsel and has served as acting general counsel since the end of February. Prior to joining BIO, DiLenge served as the chief counsel and policy director for the House Homeland Security Committee and a senior counsel for the House Energy and Commerce Committee.

DiLenge graduated summa cum laude from Fordham University in 1988 and graduated with honors from the University of Virginia School of Law in 1993.

 

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.